SAB Statement on COVID Vaccines
December 8, 2020 CONSENSUS STATEMENT BY THE ANGIOMA ALLIANCE SCIENTIFIC ADVISORY BOARD ABOUT COVID-19 VACCINE With anticipated approval by the U.S. Food and Drug Administration, long-awaited COVID-19 vaccines will soon be available. Based on exceptional effectiveness data (greater than 90% protection from COVID-19 illness), the durability of benefit after a recommended second dose, and minimal…